Pristine Flex Ostrich Mobility Wheelchair
Pristine is the most stylish powered wheelchair with revolutionary Split Frame Chassis (SFC). This indoor outdoor mobility equipment gives great comfort, stability and safety even in the toughest outdoor conditions. The body panels and the shopping basket make this equipment best suited for your kind of lifestyle.
Pristine Flex Ostrich Mobility Wheelchair Features
Split Frame Chassis (SFC).
Call alarm, fault alarm, reverse alarm (on request).
Low voltage alarm.
Key pad locking.
Mobility cut-off while charging.
Auto shut-off after 3 minutes.
Five speed selector.
Length adjustable joystick control unit (can be changed from left to right and vice versa).
Foldable, height adjustable and angle adjustable foot rest.
Wide arm rest with height and width adjustment.
Bucket seat with headrest and lap belt.
Seat can be folded for transportation.
Seat reclines 25 degrees in 6 steps.
Removable and width adjustable calf support.
Reflectors as per standards.
Head lamp.
Tail lamp.
Pristine Flex Ostrich Mobility Wheelchair Specifications
Load capacity: 110 Kg
Speed: 9.5 Kmph max
Speed selection: 5 speeds, Speed 1- 1.5Kmph, Speed 2-2.5 Kmph, speed 3- 4.8 Kmph, Speed 4- 7.2 Kmph, Speed 5- 9.5 Kmph
Power: 320W
Motor speed: 5300 rpm
Gear ratio: 32:1
Brake: Electromagnetic
Permissible Gradeability: 12 Degrees
Drive range: 32-35 Km
Ground clearance:2.5 inches
Turn circle radius: 620mm
Tire: Puncture free foam filled rubber tires
Front- Tire diameter: 220X55 mm, Rear- Tire diameter: 320X72mm, Anti tippers-1 inch solid
Battery: 24 Volt 48 Ah Sealed Maintenance Free VRLA Charger Input-230/240 Volts AC Single phase, Output-24 Volts-4 Amps DC
Overall length with footrest (at 90 degree):1180mm, Overall width:640mm, Overall height: 1250mm, Overall height after folding the seat: 690mm, Overall weight: 102 Kg
Seat depth: 500mm, Seat width:480mm, Backrest height: 540mm (without head rest), Backrest width: 440mm, Se
Một chu kỳ kinh nguyệt được tính từ ngày đầu tiên thấy kinh nguyệt cho đến ngày đầu tiên thấy kinh nguyệt của kỳ kinh kế tiếp, thông thường một chu kỳ kinh nguyệt dao động trong khoảng 21 - 32 ngày tùy vào cơ địa của mỗi người và số ngày hành kinh là 3 - 5 ngày.
M2m Vibe - Light My Fire Probe - 12 Functions - Black - with price: $32.00 - Light My Blaze is a novel test style vibrator/prostate massager. The chrome shaft curves and twists to hit simply the right spots. The silicone head is made of the most elevated value silicone ready. Featurning 12 bet
Recently, the Indian Army took the Twiterrati by surprise as it claimed to have discovered the footprints of a Yeti around the Makalu base camp of Nepal on 0th of April. Indian Army even tweeted pictures of the mythical creature of Nepali folklore as well. Their Twitter post read, " For the first time, an #IndianArmy Mountaineering Expedition Team has sited Mysterious Footprints of mythical beast 'Yeti' measuring 32×15 inches close to Makalu Base Camp on 09 April 2019. This elusive snowman has only been sighted at Makalu-Barun National Park in the past."
The global surgical equipment market size was valued at USD 9.32 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2021 to 2028
British pharmaceutical giant GlaxoSmithKline beat first-quarter sales and earnings forecasts on Wednesday (April 27), helped by demand for its Covid-19 therapy
and shingles vaccine, as the company moves towards the July separation of its consumer health business.
Profit after tax jumped 68 percent to £1.8 billion ($2.3 billion, 2.1 billion euros) compared with the start of 2021.
Sales climbed 32 percent to almost £9.8 billion.
"We have delivered strong first-quarter results in this landmark year for GSK, as we separate consumer healthcare and start a new period of sustained growth," chief
executive Emma Walmsley said in the earnings statement.
"Our results reflect further good momentum across speciality medicines and vaccines, including the return to strong sales growth for Shingrix and continuing pipeline progress."
The shingles vaccine generated £698 million in quarterly sales, beating analyst estimates of 528 million.
Walmsley is seeking to reshape GSK after facing fierce investor criticism over the company's delay in producing Covid jabs and treatments.
The recent data released by the NHS England revealed that in 2022/23 nearly 86 million antidepressant items were prescribed to around 8.6 million identified
patients.
According to the statistic published on 'Medicines Used in Mental Health' of the 5 British National Formulary (BNF) sections, 4 had increases in items and identified
patients across 2022/23.
The only BNF section to decrease since 2021/22 was hypnotics and anxiolytics. Items fell by 2% to 14 million and identified patients fell by 2 per cent to 1.9 million
in 2022/23
The data also revealed that Prescribing of Central Nervous System (CNS) stimulants and drugs for ADHD increased by 32 per cent in adults over 18 and 12 per cent in
children 17 and under.
"2022/23 was the first time that more adult patients have been prescribed drugs from this section than child patients, in the time period covered by these
statistics," said the report.
The Royal Pharmaceutical Society (RPS) has called for a 'firm commitment' to prosecuting those making profits through the sale of DNP (2,4-Dinitrophenol).
It has also urged the social media companies to 'remove content promoting or selling DNP to further reduce harm'.
Legislation to regulate DNP will come into effect on 1 October 2023. On Monday (23 January) it was announced that DNP will be included in the 1972 Poisons Act.
President of RPS Professor Claire Anderson said: "DNP is unfit for human consumption and its main use is in the manufacture of explosives and pesticides. It is
sold by unscrupulous dealers to vulnerable individuals wanting to lose weight but has a dangerous effect on the metabolism and has led to 32 deaths since 2007 in
those taking it as a 'diet drug'.
"Including DNP in the Poisons Act is a positive move as it will restrict its availability, but what's really needed is an outright ban to reduce the risk to the
public. Australia has already classified DNP as a substance of such a danger to health as to warrant prohibition of sale and we'd like the UK to follow suit.
Community pharmacies are located within the very hotspots of peoples' communities, yet a staggering 720 individual businesses have stopped trading since 2015.
It has been called a "national disgrace and a betrayal to the elderly and the vulnerable" by sector leaders.
The funding crisis has been compounded by a gruelling 18-24 months post-Covid, both have which have placed immense pressure on the retail pharmacy sector.
The population is aging and with this comes patients living with a range of long-term health conditions. Medication regimes are becoming ever more complex and as a
result, maintaining prescription and medication adherence services is challenging to say the least.
Yet the public feel great warmth towards their local pharmacy businesses, and this positive attitude only increased during the pandemic. In fact, in a recent report
launched by Omnicell on the Changing Role of the Pharmacist, a survey of public opinion found that a third (32 per cent) said they perception of their local
pharmacy had changed for the better since the start of the pandemic and nearly half (44 per cent) said they are more familiar with their local pharmacy services
since the start of COVID.
This has meant that the role of the pharmacist has also changed and evolved; in part due to a national need and drive for more patients to be seen and supported
clinically by pharmacists.
This change of service provider role has slowly been developing over the last couple of years. Pharmacists are currently carrying out 65 million consultations
a year - a staggering rise of 44 per cent in the last 24 months alone.
Pfizer's plan to sell its Haleon stake is not a surprise, the consumer health company's finance chief Tobias Hestler told Reuters on Wednesday (3 May).
London-listed Haleon was carved out as an independent company in July and comprises consumer health assets once owned by GSK and Pfizer.
Pfizer, which has a 32% stake in the maker of Sensodyne toothpaste and Panadol painkillers, told the Financial Times on Tuesday that it intends to offload that stake
in a "slow and methodical" manner within months.
Hestler said Pfizer has long been clear about its intention to sell off the stake, suggesting that the reason the potential of the selloff has gained traction is
because the selling window opens around the time that Haleon's results are announced.
"This will happen every quarter from now until they're sold off…this is just what's expected," he said, adding: "If I get a courtesy call the evening before they
do it then that would be nice, but they don't even have to do that."
Shares of the world's biggest standalone consumer health business were down more than 3% in early trading.
The government has unveiled its much awaited 'NHS Long-Term Workforce Plan' to tackle the staff shortage in the pharmacy sector. The plan set out an ambition
to increase the training places for pharmacists to around 5,000 places by 2031/32.
David Webb, Chief Pharmaceutical Officer for England, in his open letter to pharmacy professionals said: "The NHS LTWP sets out how we can build on changes,
addressing the changing needs of patients over the next 15 years, by closing the current workforce shortfall through funding for increased education and training
places and a comprehensive retention strategy."
The plan commits to expand training places for pharmacists by 29% to around 4,300 by 2028/29 and Grow the number of pharmacy technicians in future years.
"The development of independent prescribing as part of initial education and training is a gamechanger for pharmacists, patients and the NHS, with
approximately 2,800 newly registered pharmacist independent prescribers due to join the workforce every year from September 2026," said Webb.
"This will be transformational for all pharmacy teams, creating improved access and quality of care for patients and, importantly, a more flexible workforce with
skills that are equally applicable in all pharmacy settings, enabling multi-professional clinical teams to work in new ways."
The Medicines and Healthcare products Regulatory Agency (MHRA) has reminded healthcare professionals prescribing aripiprazole to alert patients about its
possible side effects, following a rise in the number of reports of gambling disorder associated with the drug.
Patients taking aripiprazole, which is used for the treatment of schizophrenia and bipolar disorder, are at risk of developing unusual urges or cravings that they
cannot resist, including behaviours such as addictive gambling, excessive eating or spending, or an abnormally high sex drive.
The regulator has received 69 reports of gambling or gambling disorder suspected to be caused by aripiprazole in the last 14 years via the Yellow Card Scheme, out
of which 32 were received between 1 January and 31 August this year.
Alison Cave, MHRA Chief Safety Officer, said: "The number of reports for suspected gambling and other impulsive behaviours associated with aripiprazole are small
in comparison to the frequency with which it is prescribed, but the consequences for any patient developing these conditions can be significant."
Health secretary Sajid Javid urged people to book a Covid-19 booster shot on Wednesday (December 1) as he said there were 22 confirmed cases of the Omicron
virus variant in the country.
Javid said the government believed a booster campaign would help protect against severe disease from Omicron, even if it turns out that vaccines are not as effective against the variant as previous strains of the disease.
He said he hoped to know more about Omicron within two weeks, as scientists work to understand what impact the new variant will have on transmissibility and serious disease.
"At this point in time the case numbers are very low," Javid told Sky News. "For the UK we've got 22 confirmed cases at the moment and that will go up, it will certainly go up."
Britain plans to offer all adults a Covid-19 booster shot by the end of January. Government data shows 81 per cent of the population aged over 12 have had two doses of the vaccine while 32 per cent have had a booster shot or third dose.
US drugs giant Pfizer will exit its consumer healthcare joint venture with GlaxoSmithKline after the unit is spun off next month, the British drugmaker
said Wednesday (June 1).
GSK will list the healthcare division on the London stock market on July 18 as it looks to concentrate on the pharmaceutical business, it said in a statement.
The London-listed firm currently owns a majority 68 percent of the unit, with Pfizer holding the remainder.
"Pfizer intends to exit its 32-percent ownership interest in Haleon in a disciplined manner, with the objective of maximising value for Pfizer shareholders," GSK
said.
Covid jab maker Pfizer is seeking to pursue its focus on "innovative medicines and vaccines", it noted.
The unit, which will be named Haleon after the demerger, makes products including Sensodyne toothpaste, pain relief drug Panadol and cold treatment Theraflu.
Community pharmacies must be involved in future planning for public health emergencies, especially in cases where a quick response is needed such as the Covid-19 pandemic, a European-wide research has recommended.
The project, co-led by the University of Huddersfield professor Zaheer-Ud-Din Babar in medicines and healthcare, focuses on how community pharmacies dealt with the pandemic, covering 31 pharmacy interventions on Covid-19 in 32 countries in Europe.
The interventions include prevention, response, and recovery measures. It also covers improved access to medicines, expanded powers granted to pharmacies, rapid antigen testing, along with Covid-19 vaccination.
Community pharmacists in the US, Canada, and Australia have been engaged in pandemic prevention, preparedness, and response strategic guidance after the 2009 flu pandemic.
The aim of the research is to map the current reported practice and trends and review the pharmacies' intervention in Europe.
Erectile dysfunction is a very common form of medical condition that occurs in males over time. Usually, this problem is found in people who take too much
medication, and ED is probably a side effect of any one of them. However, in seventy-five percent of males, the cause of erectile dysfunction is unknown, and
finding the accurate reason for it is very complex. It can be a result of any neural complications, diabetes, or any surgeries that include the prostate of our body.
ED can also be treated by using a vacuum device and surgeries on the private parts. However, it can be eradicated completely without any surgeries,
and here are some tips that will help you in overcoming erectile dysfunction without surgery and lead a happy life.
DO EXERCISE
Exercise is a great way to overcome any health issues, and also to safeguard yourself from health issues in the future. Physical activity also helps you in
controlling obesity, which is one of the reasons behind ED. By not doing regular exercises, you expose yourself to various cardiovascular problems, which contribute
to ED. Studies show that light aerobic exercise for 30-40 minutes a day for at least four times a week for at least 6 months has considerably reduced ED in people.
STAY SLIM
Studies have shown that a person who has a waist near 42 inches is more likely to suffer from ED than a person with a waistline of 32 inches. Therefore, if you
are obese it's time that you lose some weight. Excessive fat in the body is the birthplace of various diseases. Obesity is also responsible for vascular problems
and diabetes which are two primary causes of ED.
The National Health Service (NHS) on Monday launched a new national campaign to find the 'missing millions' who could be living with undiagnosed high
blood pressure, often described as a 'silent killer'.
People are being warned that the condition rarely has any symptoms and it can lead to fatal heart attacks, strokes, kidney disease and vascular dementia, if
left untreated.
According to the NHS, high blood pressure affects an estimated 32 per cent of adults and approximately three in 10 of these remain undiagnosed, equating to
4.2 million people in England.
The NHS has expanded blood pressure checks in community pharmacies to include 2.5 million more tests as part of the Pharmacy First programme.
With the 'Get Your Blood Pressure Checked' campaign, the health service is encouraging those aged 40 years and over to get a free blood pressure test at a
participating pharmacy, for which they don't need to be booked in advance.
Health Minister Andrea Leadsom expressed confidence that this new drive will help to prevent the potentially "fatal consequences" of untreated high blood
pressure. She urged people to go to their local pharmacy to get their blood pressure checked, stating that it could be a "lifesaving trip."
More than 7,000 hospitalisations and deaths in the UK could have been averted in summer 2022 if people had received their recommended COVID-19 vaccine doses,
a new study published in The Lancet has revealed.
The largest ever study carried out in the UK found that between a third and a half of the UK population had not had the recommended number of COVID vaccinations and
boosters by summer 2022.
In Northern Ireland, nearly 50 per cent of the population were under-vaccinated, while the proportion of under-vaccinated people in England was 45.7 per cent,
34.2 per cent for Scotland and 32.8 per cent Wales.
Researchers from the Health Data Research UK (HDR UK) and the University of Edinburgh analysed the electronic health records of 67 million residents aged 5 and
older from across the four countries during June 1 to September 30 2022.